PMC:7283670 / 42275-42416 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    Interferon a‐1b: 51 (100%), Lopinavir/Ritonavir: 51 [100%], Bacillus licheniformis capsules: 44 [86.3%], glucocorticoid treatment: 10 (19.6%)

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T401","span":{"begin":11,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Interferon a‐1b: 51 (100%), Lopinavir/Ritonavir: 51 [100%], Bacillus licheniformis capsules: 44 [86.3%], glucocorticoid treatment: 10 (19.6%)"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T100","span":{"begin":28,"end":37},"obj":"Chemical"},{"id":"T101","span":{"begin":105,"end":119},"obj":"Chemical"}],"attributes":[{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_24261"}],"text":"Interferon a‐1b: 51 (100%), Lopinavir/Ritonavir: 51 [100%], Bacillus licheniformis capsules: 44 [86.3%], glucocorticoid treatment: 10 (19.6%)"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T431","span":{"begin":0,"end":16},"obj":"Sentence"},{"id":"T432","span":{"begin":17,"end":48},"obj":"Sentence"},{"id":"T433","span":{"begin":49,"end":92},"obj":"Sentence"},{"id":"T434","span":{"begin":93,"end":130},"obj":"Sentence"},{"id":"T435","span":{"begin":131,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interferon a‐1b: 51 (100%), Lopinavir/Ritonavir: 51 [100%], Bacillus licheniformis capsules: 44 [86.3%], glucocorticoid treatment: 10 (19.6%)"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1152","span":{"begin":60,"end":82},"obj":"Species"},{"id":"1213","span":{"begin":28,"end":47},"obj":"Chemical"}],"attributes":[{"id":"A1152","pred":"tao:has_database_id","subj":"1152","obj":"Tax:1402"},{"id":"A1213","pred":"tao:has_database_id","subj":"1213","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Interferon a‐1b: 51 (100%), Lopinavir/Ritonavir: 51 [100%], Bacillus licheniformis capsules: 44 [86.3%], glucocorticoid treatment: 10 (19.6%)"}